- 首页
- PKD (Protein kinase D)
- C16 Lactosylceramide-d3 (d18:1/16:0-d3)
C16 Lactosylceramide-d3 (d18:1/16:0-d3)
A neuropeptide with diverse biological activities
此产品仅用于科学研究，我们不为任何个人用途提供产品和服务
-
包装价格促销价数量
-
1mg￥9450.007560.00- +
- 货号: ajcx21892
- CAS: N/A
- 别名: C16 Lactosyl(β) Ceramide-d3 (d18:1/16:0-d3), LacCer(d18:1/16:0-d3), Lactosylceramide-d3 (d18:1/16:0-d3), N-ω-CD3-Hexadecanoyl-lactosylceramide, N-Hexadecanoyl Lactosylceramide-d3
- 分子式: C46H84D3NO13
- 分子量: 865.2
- 纯度: ＞98%
- 溶解度: Chloroform:Methanol:Water (5:1:0.1): soluble
- 储存: Store at -20°C
- 库存: 现货
Background
C16 Lactosylceramide-d3 (d18:1/16:0-d3) is intended for use as an internal standard for the quantification of C16 lactosylceramide by GC- or LC-MS. C16 Lactosylceramide is an endogenous bioactive sphingolipid.1 It forms membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors (GPCRs), suggesting a role in cell signaling. Plasma levels of C16 lactosylceramide are elevated in insulin-resistant cattle.2 C16 Lactosylceramide is also upregulated in a mouse model of Niemann-Pick type C1 disease, a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder.3 [Matreya, LLC. Catalog No. 1534]
1.Iwabuchi, K., Nakayama, H., Oizumi, A., et al.Role of ceramide from glycosphingolipids and its metabolites in immunological and inflammatory responses in humansMediators Inflamm.2015120748(2015) 2.Rico, J.E., Bandaru, V.V., Dorskind, J.M., et al.Plasma ceramides are elevated in overweight Holstein dairy cows experiencing greater lipolysis and insulin resistance during the transition from late pregnancy to early lactationJ. Dairy Sci.98(11)7757-7770(2015) 3.Praggastis, M., Tortelli, B., Zhang, J., et al.A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease alleleJ. Neurosci.35(21)8091-8106(2015)
